Interestingly, while both high and low androgen doses can activate mTOR, only low doses induce expression of c-MYC, a major oncogenic driver in PCa, whereas high doses suppress c-MYC expression [69]. The gene discussed is MTOR; the disease is posterior cortical atrophy.